In vitro inhibition of enterobacteria-reactive CD4+CD25− T cells and suppression of immunoinflammatory colitis in mice by the novel immunomodulatory agent VGX-1027
In vitro inhibition of enterobacteria-reactive CD4+CD25− T cells and suppression of immunoinflammatory colitis in mice by the novel immunomodulatory agent VGX-1027
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation